• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Greg Heydet, USA

      Greg Heydet, USA

    • David Solomon, UK

      David Solomon, UK

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Verónica Isabel Castro Molina, Argentina

      Verónica Isabel Castro Molina, Argentina

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Chen Yin Xue, Taiwan

      Chen Yin Xue, Taiwan

    • Ali Var, Turkey

      Ali Var, Turkey

    • David Hall, USA

      David Hall, USA

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • Liam Dwyer, England

      Liam Dwyer, England

    • Eric Von Schaumburg, USA

      Eric Von Schaumburg, USA

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • Anna Barrow, UK

      Anna Barrow, UK

    • Lachlan Terry, Australia

      Lachlan Terry, Australia

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Federica Mastrosimone, Italy

      Federica Mastrosimone, Italy

    • Chun Ju Xiao, China

      Chun Ju Xiao, China

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Angela Jansen, Germany

      Angela Jansen, Germany

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Lin Yong Yi, Taiwan

      Lin Yong Yi, Taiwan

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • John Russo, USA

      John Russo, USA
      final3878

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Purningam Jacob, India

      Purningam Jacob, India

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Mirca Bersani, Italy

      Mirca Bersani, Italy
      MircaBersani

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Bob Simonds, USA

      Bob Simonds, USA

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Antonio Ventriglia, Belgium

      Antonio Ventriglia, Belgium

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Ann Nicol, USA

      Ann Nicol, USA

    • Mauril Belanger, Canada

      Mauril Belanger, Canada

    • Tso-Ta Huang, Taiwan

      Tso-Ta Huang, Taiwan

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Mahmood Anwar, UK

      Mahmood Anwar, UK

    • Camilla Heiberg Freiberg, Denmark

      Camilla Heiberg Freiberg, Denmark

    • Jason Goodman, USA

      Jason Goodman, USA

    • Ali Var, Turkey

      Ali Var, Turkey

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login